Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712296 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of Chinese Herbal Therapy for Asthma
A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT00712296 is a Phase 1 study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 66 participants.
The verdict
NCT00712296, a Phase 1 study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of an anti-asthma herbal medicine intervention (ASHMI) in adult asthmatics
Interventions
- DRUG Placebo
- DRUG ASHMI 4
- DRUG ASHMI 12
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-09-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00712296
The ClinicalTrials.gov registry entry for NCT00712296 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00712296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00712296 about?
NCT00712296 is a clinical study titled "Effectiveness of Chinese Herbal Therapy for Asthma". The purpose of this study is to determine the efficacy of an anti-asthma herbal medicine intervention (ASHMI) in adult asthmatics
What is the current status of trial NCT00712296?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2008-08. Estimated completion is 2009-09-29.
What interventions are being tested in trial NCT00712296?
The interventions under investigation include: Placebo (DRUG), ASHMI 4 (DRUG), ASHMI 12 (DRUG).
Who is sponsoring clinical trial NCT00712296?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.